| Year |
Title |
Altmetric |
| 2020
|
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform.
Human Mutation.
41:1131-1137.
2020
|
|
| 2020
|
GFAP at 50.
ASN Neuro.
12.
2020
|
|
| 2019
|
Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
Journal of Biological Chemistry.
294:15604-15612.
2019
|
|
| 2019
|
AP-1 and the injury response of the GFAP gene.
Journal of Neuroscience Research.
97:149-161.
2019
|
|
| 2016
|
Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.
Journal of Proteome Research.
15:2265-2282.
2016
|
|
| 2015
|
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
Glia.
63:2285-2297.
2015
|
|
| 2015
|
A new mutation in GFAP widens the spectrum of Alexander disease.
European Journal of Human Genetics.
23:1-2.
2015
|
|
| 2014
|
Changes in the morphology and proliferation of astrocytes induced by two modalities of chemically functionalized single-walled carbon nanotubes are differentially mediated by glial fibrillary acidic protein
2014
|
|
| 2014
|
Role of GFAP in CNS injuries.
Neuroscience Letters.
565:7-13.
2014
|
|
| 2013
|
Transgenic analysis of GFAP promoter elements.
Glia.
61:1488-1499.
2013
|
|
| 2012
|
Splice site, frameshift, and chimeric GFAP mutations in Alexander disease.
Human Mutation.
33:1141-1148.
2012
|
|
| 2012
|
Alexander disease
2012
|
|
| 2012
|
Archetypal and new families with Alexander disease and novel mutations in GFAP.
Archives of Neurology.
69:208-214.
2012
|
|
| 2011
|
GFAP mutations, age at onset, and clinical subtypes in Alexander disease.
Neurology.
77:1287-1294.
2011
|
|
| 2010
|
Alteration Of glial-neuronal metabolic interactions in a mouse model of Alexander disease.
Glia.
58:1228-1234.
2010
|
|
| 2010
|
Drug screening to identify suppressors of GFAP expression.
Human Molecular Genetics.
19:3169-3178.
2010
|
|
| 2009
|
An infantile case of Alexander disease unusual for its MRI features and a GFAP allele carrying both the p.Arg79His mutation and the p.Glu223Gln coding variant.
Journal of Neurology.
256:679-682.
2009
|
|
| 2008
|
Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.
Journal of Gene Medicine.
10:583-592.
2008
|
|
| 2008
|
GFAP promoter elements required for region-specific and astrocyte-specific expression.
Glia.
56:481-493.
2008
|
|
| 2008
|
Adult-onset Alexander disease with progressive ataxia and palatal tremor.
Movement Disorders.
23:118-122.
2008
|
|
| 2007
|
GFAP and its role in Alexander disease.
Experimental Cell Research.
313:2077-2087.
2007
|
|
| 2006
|
Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Journal of Clinical Neuroscience.
13:934-938.
2006
|
|
| 2006
|
Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Glia.
53:677-687.
2006
|
|
| 2006
|
Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
Journal of Neuroscience Research.
83:744-753.
2006
|
|
| 2006
|
Propensity for paternal inheritance of de novo mutations in Alexander disease.
Human Genetics.
119:137-144.
2006
|
|
| 2006
|
The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of αB-crystallin and HSP27.
American Journal of Human Genetics.
79:197-213.
2006
|
|
| 2005
|
Erratum: Unusual variants of Alexander's disease (Annals of Neurology (2005) 57 (327-338)).
Annals of Neurology.
58:172.
2005
|
|
| 2005
|
Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
Journal of Cell Science.
118:2057-2065.
2005
|
|
| 2005
|
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
Annals of Neurology.
57:310-326.
2005
|
|
| 2005
|
Unusual variants of Alexander's disease.
Annals of Neurology.
57:327-338.
2005
|
|
| 2004
|
Expression specificity of GFAP transgenes.
Neurochemical Research.
29:2075-2093.
2004
|
|
| 2004
|
Expression specificity of GFAP transgenes..
Neurochemical Research.
29:2075-2093.
2004
|
|
| 2004
|
Dominantly-inherited adult-onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene.
Movement Disorders.
19:1244-1248.
2004
|
|
| 2004
|
Expression of glial fibrillary acidic protein in primary cultures of human Müller cells.
Experimental Eye Research.
79:423-429.
2004
|
|
| 2003
|
Alexander's disease: Clinical, pathologic, and genetic features.
Journal of Child Neurology.
18:625-632.
2003
|
|
| 2003
|
GFAP: Functional implications gleaned from studies of genetically engineered mice.
Glia.
43:87-90.
2003
|
|
| 2003
|
Alexander disease: GFAP mutations unify young and old.
Lancet Neurology.
2:75.
2003
|
|
| 2002
|
GFAP mutations in Alexander disease.
International Journal of Developmental Neuroscience.
20:259-268.
2002
|
|
| 2002
|
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients.
Neurology.
58:1494-1500.
2002
|
|
| 2002
|
ICP monitoring following bilateral carotid occlusion in GFAP-null mice
2002
|
|
| 2001
|
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
2001
|
|
| 2001
|
A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease.
Neuroscience Letters.
312:71-74.
2001
|
|
| 2001
|
Differential cellular expression of tumor necrosis factor-α and Type I tumor necrosis factor receptor after transient global forebrain ischemia.
Journal of the Neurological Sciences.
186:87-99.
2001
|
|
| 2001
|
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.
Nature Genetics.
27:117-120.
2001
|
|
| 2001
|
Alexander disease: New insights from genetics.
Journal of Neuropathology and Experimental Neurology.
60:563-573.
2001
|
|
| 2001
|
Infantile Alexander disease: Spectrum of GFAP mutations and genotype-phenotype correlation.
American Journal of Human Genetics.
69:1134-1140.
2001
|
|
| 2001
|
Update on white matter genetic disorders (multiple letters) [2].
Pediatric Neurology.
25:347-348.
2001
|
|
| 2000
|
High susceptibility to cerebral ischemia in GFAP-null mice.
Journal of Cerebral Blood Flow and Metabolism.
20:1040-1044.
2000
|
|
| 2000
|
Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Cancer Gene Therapy.
7:1120-1126.
2000
|
|
| 1999
|
Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene.
Life Sciences.
65:483-491.
1999
|
|
| 1999
|
Biosynthetic capacity of C6 cells engineered with a glial fibrillary acidic protein-tyrosine hydroxylase transgene.
Medical Science Research.
27:423-425.
1999
|
|
| 1999
|
Nonlethal detection of transgene expression in the CNS of founder mice
1999
|
|
| 1999
|
TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via ceramide
1999
|
|
| 1998
|
Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation
1998
|
|
| 1998
|
Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene.
Cancer Research.
58:4577-4580.
1998
|
|
| 1998
|
Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain rosenthal fibers.
Journal of Neuroscience Research.
53:353-360.
1998
|
|
| 1998
|
Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury.
NeuroReport.
9:1691-1696.
1998
|
|
| 1998
|
Differentiation-dependent expression of transgenes in engineered astrocyte cell lines.
Neuroscience Letters.
242:172-176.
1998
|
|
| 1998
|
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.
American Journal of Pathology.
152:391-398.
1998
|
|
| 1998
|
Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism
1998
|
|
| 1998
|
Chronic relapsing experimental autoimmune encephalomyelitis: Effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects.
Journal of Neuropathology and Experimental Neurology.
57:426-438.
1998
|
|
| 1998
|
Stimulation of tyrosine phosphorylation of a brain protein by hibernation.
Journal of Cerebral Blood Flow and Metabolism.
18:1040-1045.
1998
|
|
| 1997
|
Global forebrain ischemia results in differential cellular expression of interleukin-1β (IL-1β) and its receptor at mRNA and protein level.
Journal of Cerebral Blood Flow and Metabolism.
17:1107-1120.
1997
|
|
| 1996
|
Conditional ablation of cerebellar astrocytes in postnatal transgenic mice
1996
|
|
| 1996
|
Decreased calcium accumulation in isolated nerve endings during hibernation in ground squirrels.
Neurochemical Research.
21:947-954.
1996
|
|
| 1996
|
Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology
1996
|
|
| 1996
|
GFAP transgenic mice.
Methods.
10:351-364.
1996
|
|
| 1996
|
Somatostatin as a trophic factor: Analysis of transgenic mice overexpressing somatostatin in astrocytes.
Annals of the New York Academy of Sciences.
780:29-35.
1996
|
|
| 1995
|
A novel glial fibrillary acidic protein mRNA lacking exon 1.
Brain Research.
30:251-258.
1995
|
|
| 1995
|
Astrocytes Upregulate Glial Fibrillary Acidic Protein (GFAP), but not Insulin‐like Growth Factor‐I (IGF‐I) during Experimental Autoimmune Neuritis (EAN).
Brain Pathology.
5:1-10.
1995
|
|
| 1995
|
Cryogenic spinal cord injury induces astrocytic gene expression of insulin‐like growth factor I and insulin‐like growth factor binding protein 2 during myelin regeneration.
Journal of Neuroscience Research.
40:647-659.
1995
|
|
| 1995
|
Overexpression of TGF-ß1 in the central nervous system of transgenic mice results in hydrocephalus.
Journal of Neuropathology and Experimental Neurology.
54:339-349.
1995
|
|
| 1994
|
Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
Molecular and Cellular Neuroscience.
5:418-430.
1994
|
|
| 1994
|
Concentric sclerosis (Baló): Morphometric and in situ hybridization study of lesions in six patients.
Annals of Neurology.
35:18-30.
1994
|
|
| 1994
|
Cyclic AMP Decreases the Expression of a Neuronal Marker (GAD67) and Increases the Expression of an Astroglial Marker (GFAP) in C6 Cells.
Journal of Neurochemistry.
63:1218-1225.
1994
|
|
| 1994
|
Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration.
Experimental Neurology.
128:202-210.
1994
|
|
| 1994
|
GFAP promoter directs astrocyte-specific expression in transgenic mice
1994
|
|
| 1994
|
Structure and Transcriptional Regulation of the GFAP Gene.
Brain Pathology.
4:245-257.
1994
|
|
| 1993
|
Analysis of a Segment of the Human Glial Fibrillary Acidic Protein Gene That Directs Astrocyte‐Specific Transcription.
Journal of Neurochemistry.
61:160-166.
1993
|
|
| 1992
|
Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes
1992
|
|
| 1991
|
Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein.
Journal of Biological Chemistry.
266:18877-18883.
1991
|
|
| 1991
|
Quantitation of ColE1-encoded replication elements
1991
|
|
| 1990
|
A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID.
Nature.
348:86-88.
1990
|
|
| 1990
|
An RNA polymerase II promoter containing sequences upstream and downstream from the RNA startpoint that direct initiation of transcription from the same site
1990
|
|
| 1990
|
Characterization of human cDNA and genomic clones for glial fibrillary acidic protein.
Brain Research.
7:277-286.
1990
|
|
| 1989
|
Rom transcript of plasmid ColE1.
Nucleic Acids Research.
17:4309-4326.
1989
|
|
| 1985
|
The role of enzyme sequestration in the regulation of the adenylate cyclase of Dictyostelium discoideum.
Journal of Biological Chemistry.
260:3613-3616.
1985
|
|
| 1984
|
Transmembrane signaling in Dictyostelium discoideum: A possible mechanism.
The FASEB Journal.
43.
1984
|
|
| 1983
|
Forskolin does not activate cyclic AMP synthesis in Dictyostelium discoideum in vivo or in vitro.
Journal of cyclic nucleotide and protein phosphorylation research.
9:297-303.
1983
|
|
